Batten, S.; Kumar, H.; Pfitzer, J.; Nweze, D.C.; Mazumder, S.; Arnold, R.D.; Mistriotis, P.; Mitra Ghosh, T.; Mitra, A.K.
Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer. Int. J. Mol. Sci. 2025, 26, 10892.
https://doi.org/10.3390/ijms262210892
AMA Style
Batten S, Kumar H, Pfitzer J, Nweze DC, Mazumder S, Arnold RD, Mistriotis P, Mitra Ghosh T, Mitra AK.
Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer. International Journal of Molecular Sciences. 2025; 26(22):10892.
https://doi.org/10.3390/ijms262210892
Chicago/Turabian Style
Batten, Sarah, Harish Kumar, Jeremiah Pfitzer, Daniel Chinedu Nweze, Suman Mazumder, Robert D. Arnold, Panagiotis Mistriotis, Taraswi Mitra Ghosh, and Amit Kumar Mitra.
2025. "Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer" International Journal of Molecular Sciences 26, no. 22: 10892.
https://doi.org/10.3390/ijms262210892
APA Style
Batten, S., Kumar, H., Pfitzer, J., Nweze, D. C., Mazumder, S., Arnold, R. D., Mistriotis, P., Mitra Ghosh, T., & Mitra, A. K.
(2025). Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer. International Journal of Molecular Sciences, 26(22), 10892.
https://doi.org/10.3390/ijms262210892